Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v2.4.0.8
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues        
Product $ 2,695 $ 3,456 $ 5,491 $ 6,177
Product licensing fees 378 397 752 830
Service 191 236 413 454
Total revenues 3,264 4,089 6,656 7,461
Cost of revenues        
Product 1,368 1,203 2,690 2,224
Service 164 181 328 332
Total cost of revenues 1,532 1,384 3,018 2,556
Gross profit 1,732 2,705 3,638 4,905
Operating expenses        
Research and development 353 883 792 1,390
Selling, general and administrative 2,923 3,093 5,904 5,912
Total operating expenses 3,276 3,976 6,696 7,302
Loss from operations (1,544) (1,271) (3,058) (2,397)
Interest expense (1) (188) (4) (438)
Interest income 0 0 0 1
Gain (loss) due to change in fair value of common stock 0 99 0 (210)
Gain due to change in fair value of derivative liabilities (See Note 5) 841 0 2,319 0
Other expense, net (14) (39) (45) (67)
Net loss (718) (1,399) (788) (3,111)
Net loss per common share: basic and diluted $ (0.08) $ (0.21) $ (0.09) $ (0.47)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted 8,503 6,631 8,425 6,625
Other comprehensive loss, net of tax        
Net loss (718) (1,399) (788) (3,111)
Foreign currency translation adjustments (110) 13 (102) (86)
Comprehensive loss $ (828) $ (1,386) $ (890) $ (3,197)